1. Centromedian thalamic deep brain stimulation for idiopathic generalized epilepsy: Connectivity and target optimization.
- Author
-
Park S, Permezel F, Agashe S, Osman G, Simpson HD, Miller KJ, Van Gompel JJ, Starnes K, Lundstrom BN, Worrell GA, and Gregg NM
- Subjects
- Humans, Female, Male, Retrospective Studies, Adult, Treatment Outcome, Young Adult, Adolescent, Middle Aged, Epilepsy, Generalized therapy, Epilepsy, Generalized physiopathology, Deep Brain Stimulation methods, Intralaminar Thalamic Nuclei, Drug Resistant Epilepsy therapy, Drug Resistant Epilepsy physiopathology
- Abstract
There are limited treatment options for individuals with drug-resistant idiopathic generalized epilepsy (IGE). Small, limited case series suggest that centromedian thalamus deep brain stimulation (CM-DBS) may be an effective treatment option. The optimal CM-DBS target for IGE is underexamined. Here, we present a retrospective analysis of CM-DBS targeting and efficacy for five patients with drug-resistant IGE. Volume of tissue activated (VTA) overlap with CM nucleus was performed using an open-source toolbox. Median follow-up time was 13 months. Median convulsive seizure frequency reduction was 66%. One patient had only absence seizures, with >99% reduction in absence seizure frequency. Four patients had electrode contacts positioned within the CM nucleus target, all of whom had >50% reduction in primary semiology seizure, with 85% median seizure reduction (p = .004, paired-sample t test). Volumetric "sweet-spot" mapping revealed that best outcomes were correlated with stimulation of the middle ventral CM nucleus. Connectivity strength between the sweet-spot region and central peri-Rolandic cortex was increased significantly relative to other cortical regions (p = 8.6 × 10
-4 , Mann-Whitney U test). Our findings indicate that CM-DBS can be an effective treatment for patients with IGE, highlight the importance of accurate targeting and targeting analysis, and within the context of prior work, suggest that ideal CM-DBS targets may be syndrome specific., (© 2024 International League Against Epilepsy.)- Published
- 2024
- Full Text
- View/download PDF